| 1 |
32532074 | Ibrutinib in Gynecological Malignancies and Breast Cancer: A Systematic Review. | 2020 Jun 10 |
2 |
| 2 |
28972595 | Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1/PD-L1 pathway. | 2018 Apr |
2 |
| 3 |
30209121 | B-cell receptor-mediated NFATc1 activation induces IL-10/STAT3/PD-L1 signaling in diffuse large B-cell lymphoma. | 2018 Oct 25 |
1 |
| 4 |
28641100 | Bruton's tyrosine kinase (BTK) as a promising target in solid tumors. | 2017 Jul |
1 |
| 5 |
28123879 | Ibrutinib as an antitumor immunomodulator in patients with refractory chronic lymphocytic leukemia. | 2016 |
1 |